Inventor · disambiguated record
Beth A. Burnside
Also filed as: BURNSIDE BETH · BURNSIDE BETH A
39 granted patents·20 pending applications·2,317 citations·filing 1995–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US6913768B2Sustained release delivery of amphetamine saltsSHIRE LAB INC·Filed 2003·Granted Jul 5, 2005·266 cites·37 claims
- 0298US6322819B1Oral pulsed dose drug delivery systemSHIRE LAB INC·Filed 1998·Granted Nov 27, 2001·348 cites·24 claims
- 0398US6287599B1Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profilesSHIRE LAB INC·Filed 2000·Granted Sep 11, 2001·216 cites·30 claims
- 0497US6361796B1Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2000·Granted Mar 26, 2002·87 cites·21 claims
- 0597US6284276B1Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2000·Granted Sep 4, 2001·106 cites·26 claims
- 0696US6814979B2Osmotic drug delivery systemSHIRE LAB INC·Filed 2002·Granted Nov 9, 2004·61 cites·15 claims
- 0796US6811794B2Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profilesSHIRE LAB INC·Filed 2001·Granted Nov 2, 2004·105 cites·12 claims
- 0895US7011846B2Oral capsule formulation with increased physical stabilitySHIRE LAB INC·Filed 2002·Granted Mar 14, 2006·76 cites·9 claims
- 0994US6605300B1Oral pulsed dose drug delivery systemSHIRE LAB INC·Filed 1999·Granted Aug 12, 2003·118 cites·18 claims
- 1094US6514532B2Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2001·Granted Feb 4, 2003·43 cites·15 claims
- 1194US5824638AOral insulin deliverySHIRE LAB INC·Filed 1995·Granted Oct 20, 1998·190 cites·18 claims
- 1293USRE42096EOral pulsed dose drug delivery systemSHIRE LLC USA·Filed 2005·Granted Feb 1, 2011·28 cites·25 claims
- 1393US6110498AOsmotic drug delivery systemSHIRE LAB INC·Filed 1997·Granted Aug 29, 2000·118 cites·28 claims
- 1492US5952004AEmulsified drug delivery systemsSHIRE LAB INC·Filed 1995·Granted Sep 14, 1999·117 cites·19 claims
- 1590US6890918B2Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancersSHIRE LAB INC·Filed 2002·Granted May 10, 2005·38 cites·18 claims
- 1689US8906413B2Drug formulations having reduced abuse potentialCHANG RONG-KUN·Filed 2003·Granted Dec 9, 2014·24 cites·23 claims
- 1789US6838093B2System for osmotic delivery of pharmaceutically active agentsSHIRE LAB INC·Filed 2001·Granted Jan 4, 2005·54 cites·20 claims
- 1888US6692767B2Solid solution beadletSHIRE LAB INC·Filed 1998·Granted Feb 17, 2004·88 cites·23 claims
- 1987US5897876AEmulsified drug delivery systemSHIRE LAB INC·Filed 1997·Granted Apr 27, 1999·75 cites·24 claims
- 2085USRE41148EOral pulsed dose drug delivery systemSHIRE LLC·Filed 1999·Granted Feb 23, 2010·42 cites·20 claims
- 2179US9144551B2Drug formulations having reduced abuse potentialSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Sep 29, 2015·1 cites·15 claims
- 2278US8357394B2Compositions and methods for improved efficacy of penicillin-type antibioticsShionogi Inc·Filed 2006·Granted Jan 22, 2013·3 cites·7 claims
- 2378US7022337B2Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effectSHIRE LAB INC·Filed 2003·Granted Apr 4, 2006·17 cites·19 claims
- 2471US8460710B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Jun 11, 2013·3 cites·37 claims
- 2570US8062672B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Nov 22, 2011·2 cites·42 claims
- 2670US5948407AOral induction of tolerance to parenterally administered non-autologous polypeptidesSHIRE LAB INC·Filed 1998·Granted Sep 7, 1999·32 cites·16 claims
- 2766US6793934B1Solid oral dosage formSHIRE LAB INC·Filed 1999·Granted Sep 21, 2004·27 cites·26 claims
- 2866US5883103AOral acyclovir deliverySHIRE LAB INC·Filed 1995·Granted Mar 16, 1999·31 cites·18 claims
- 2965US8299052B2Pharmaceutical compositions and methods for improved bacterial eradicationFLANNER HENRY H·Filed 2007·Granted Oct 30, 2012·1 cites·10 claims
- 3065US2004219213A1Oral pulsed dose drug delivery systemFiled 2004·Application pending·0 cites
- 3158US2025268976A1Broad-spectrum peptoids for treatment or prevention of wound infections, and compositions and methods of use thereofMAXWELL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3257US2008139526A1Modified release dosage forms of amoxicillinTREACY DONALD·Filed 2006·Application pending·0 cites
- 3356US9144548B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2011·Granted Sep 29, 2015·0 cites·19 claims
- 3456US2004005339A1Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailabilityFiled 2002·Application pending·0 cites
- 3555US8425936B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Apr 23, 2013·0 cites·17 claims
- 3655US8313775B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Nov 20, 2012·0 cites·16 claims
- 3755US8246996B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Aug 21, 2012·0 cites·34 claims
- 3855US2019358687A1Disposal of medicamentsDISPOSERX INC·Filed 2019·Application pending·0 cites
- 3954US2003124188A1Oral pulsed dose drug delivery systemFiled 2002·Application pending·0 cites
- 4054US2005142187A1Enhanced absorption of modified release dosage formsFiled 2004·Application pending·0 cites
- 4154US2014212490A1Tablet for pulsed deliveryShionogi Inc·Filed 2014·Application pending·0 cites
- 4253US2010120896A1Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureusSANDER SANNA·Filed 2009·Application pending·0 cites
- 4352US10532385B2Disposal of medicamentsDISPOSERX INC·Filed 2017·Granted Jan 14, 2020·0 cites·18 claims
- 4452US2010016333A1Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureusFLANNER HENRY H·Filed 2007·Application pending·0 cites
- 4551US8715727B2Tablet for pulsed deliveryCAO BRUCE·Filed 2005·Granted May 6, 2014·0 cites·10 claims
- 4651US2004028729A1Pharmaceutical formulations with improved bioavailabilityFiled 2003·Application pending·0 cites
- 4751US2006193908A1Extended release formulations of poorly soluble antibioticsBURNSIDE BETH A·Filed 2005·Application pending·0 cites
- 4850US9125803B2Gastric release pulse system for drug deliveryFLANNER HENRY H·Filed 2006·Granted Sep 8, 2015·0 cites·9 claims
- 4950US2014187842A1Device for Disposal and Neutralization of Pharmaceutical AgentsQRXPHARMA LTD·Filed 2013·Application pending·0 cites
- 5050US2005158384A1Sustained release delivery of amphetamine saltsFiled 2005·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Beth A. Burnside files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →